09.12.26 -- Bioprocess Online Newsletter - Best Of August

Moving into GMP manufacturing can bring costly challenges—from sourcing and validating materials to regulatory compliance, risk assessment, and facility fit. Join Bioprocess Online’s Tyler Menichiello and industry experts Wei Lu, Ph.D., Tiffany Rau, Ph.D., and Mary Rodley 9/18/26 at 11 AM ET for an interactive panel on phase-appropriate CMC decisions and material selection. Discover key considerations for implementing GMP-grade materials and equipment while preparing your process for successful clinical manufacturing. Register today!

Biotechs often default to one of two flawed instincts: pursue the biggest name in the space or go with the lowest bidder. To avoid misalignment, look at these less visible factors.

In this segment from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration,” our panelists discuss the challenges development teams face when upstream and downstream teams operate concurrently in a vacuum.

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients.

Explore various strategies to enhance viral titer and increase the percentage of full AAV capsids, like modifications to transfection reagents, cell lines, media, procedures, and more.

Your ADC handling protocol may have gaps you have not accounted for yet. Examine seven considerations that are reshaping how manufacturers protect product integrity and operator safety.

Learn a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.